Yanuki
Health / Policy
AstraZeneca, a U.K.-based drugmaker, struck a deal with the Trump administration to lower drug prices for Medicaid and offer discounts directly to consumers through the TrumpRx website. This initiative aims to align U.S. drug prices with th...
News / Politics
President Donald Trump has announced a deal with AstraZeneca to lower drug prices in the United States. The agreement aims to make prescriptions more affordable, particularly for low-income Americans.
Health / Vaccines
AstraZeneca is making flu protection more convenient by launching an at-home delivery option for FluMist, its nasal spray flu vaccine. Approved by the FDA for self-administration, FluMist offers a needle-free alternative for eligible indivi...
Business / Pharmaceuticals
AstraZeneca is set to invest $50 billion in the U.S. by 2030, boosting its manufacturing and research capabilities. This move aligns with a broader trend of pharmaceutical firms increasing their U.S. investments amidst evolving trade polici...
Finance / Stocks
This article summarizes the latest investor updates on trending stocks as of July 16, 2025, providing a concise overview of factors influencing their performance.
Pharma / Oncology
This article summarizes key developments in the pharmaceutical industry, including AstraZeneca's positive Phase 3 trial results for Imfinzi, Roche's investment in a new manufacturing site in China, and promising advancements in bladder canc...
